New insights into the anti-diabetic actions of metformin: from the liver to the gut-Reference-Cited by-同舟云学术

New insights into the anti-diabetic actions of metformin: from the liver to the gut

Published:2016-12-26 Issue:2 Volume:11 Page:157-166
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Wu Tongzhi¹,Horowitz Michael¹,Rayner Christopher K.¹

Affiliation:

1. Discipline of Medicine and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Australia

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2017.1273769

Reference86 articles.

1. Über Biguanide, II.: Die blutzucker‐senkende Wirkung der Biguanide

2. Metformin in Patients With Type 2 Diabetes and Kidney Disease

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

4. Cardiovascular Outcomes in Trials of Oral Diabetes Medications

5. Metformin effects revisited

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extraction, phytochemicals characterization, in vivo and in vitro anti-diabetic ability of non-extractable polyphenols from Undaria pinnatifida;Food Research International;2024-11

2. Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis;Pharmaceuticals;2024-07-05

3. Regulating the absorption and excretion of perfluorooctane sulfonate and its alternatives through influencing enterohepatic circulation;Science of The Total Environment;2024-07

4. Region-Specific Effects of Metformin on Gut Microbiome and Metabolome in High-Fat Diet-Induced Type 2 Diabetes Mouse Model;International Journal of Molecular Sciences;2024-06-30

5. Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study;Diabetologia;2024-04-01